Amrix

Watson Pharmaceuticals (NYSE: WPI) is scheduled to report its second-quarter 2011 results Tuesday, July 26, before the markets open. Strong first-quarter results pushed the share price to a new all-time high; can second-quarter results do the same? Analysts are looking for the drug maker to report...

On Friday, Cephalon (NASDAQ: CEPH) announced that the U.S. District Court of Delaware ruled in favor of Watson with respect to two patents surrounding Fentora. The Court has yet to rule on the last of the three patents in question. The ruling is sure to stir further anxiety regarding the extent of...